Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

Professor Mohanasankar Sivaprakasam, director of the Healthcare Technology Innovation Centre and the Sudha Gopalakrishnan ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Back in February, newly-confirmed Secretary of Health and & Human Services (HHS) Robert F. Kennedy Jr. promised to reverse decades of industry capture ...

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

If a policy to lower the price of generic drugs to 40% of original pharmaceuticals is implemented, there are claims that the ...

The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges. With a market value exceeding $280 ...

In a year of increasing scrutiny on health care and cost of medicines, pharmaceuticals continued to soar in importance for ...

Over 500 industry leaders gathered at the Dublin Royal Convention Centre to celebrate excellence in Ireland’s pharma sector ...

Cost audit applies to pharma companies crossing prescribed turnover limits, ensuring transparency and compliance with price controls under the ...